IL165505A0 - 2-heteroaryl carboxamides - Google Patents

2-heteroaryl carboxamides

Info

Publication number
IL165505A0
IL165505A0 IL16550504A IL16550504A IL165505A0 IL 165505 A0 IL165505 A0 IL 165505A0 IL 16550504 A IL16550504 A IL 16550504A IL 16550504 A IL16550504 A IL 16550504A IL 165505 A0 IL165505 A0 IL 165505A0
Authority
IL
Israel
Prior art keywords
heteroaryl carboxamides
carboxamides
heteroaryl
prophylaxis
learning
Prior art date
Application number
IL16550504A
Other languages
English (en)
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of IL165505A0 publication Critical patent/IL165505A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL16550504A 2002-06-10 2004-12-02 2-heteroaryl carboxamides IL165505A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide
PCT/EP2003/005735 WO2003104227A1 (de) 2002-01-20 2003-06-02 2-heteroarylcarbonsäureamide

Publications (1)

Publication Number Publication Date
IL165505A0 true IL165505A0 (en) 2006-01-15

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16550504A IL165505A0 (en) 2002-06-10 2004-12-02 2-heteroaryl carboxamides

Country Status (16)

Country Link
US (5) US7977485B2 (ja)
EP (1) EP1515967B1 (ja)
JP (1) JP4542891B2 (ja)
CN (1) CN1675204A (ja)
AT (1) ATE344262T1 (ja)
AU (1) AU2003238450A1 (ja)
BR (1) BR0312446A (ja)
CA (1) CA2488761C (ja)
DE (1) DE50305587D1 (ja)
ES (1) ES2276072T3 (ja)
IL (1) IL165505A0 (ja)
MX (1) MXPA04012439A (ja)
NO (1) NO20050063L (ja)
PL (1) PL374551A1 (ja)
UY (1) UY27841A1 (ja)
WO (1) WO2003104227A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
EP1515967B1 (de) * 2002-06-10 2006-11-02 Bayer HealthCare AG 2-heteroarylcarbonsäureamide
AU2003276919B2 (en) * 2002-09-25 2013-05-16 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
WO2005016923A1 (en) 2003-08-13 2005-02-24 Neurosearch A/S Novel quinuclidine derivatives and their pharmaceutical use
RS20060391A (en) * 2003-12-22 2008-11-28 Memory Pharmaceuticals Corporation, Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
CN103724343A (zh) 2004-03-25 2014-04-16 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途
EP1751150A2 (en) 2004-05-19 2007-02-14 Neurosearch A/S Novel azabicyclic aryl derivatives
US7652010B2 (en) * 2004-10-15 2010-01-26 Neurosearch A/S Azabicyclic aryl derivatives and their medical use
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
WO2009081970A1 (ja) * 2007-12-26 2009-07-02 Eisai R & D Management Co., Ltd. ヘテロ環置換ピリジン誘導体の製造方法
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
AR081402A1 (es) 2010-05-17 2012-08-29 Envivo Pharmaceuticals Inc Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
CN103380129B (zh) 2010-12-20 2016-04-20 阿克图拉姆生命科学股份公司 2-甲酰胺-4-哌嗪基-苯并呋喃衍生物
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法
EP4213832A4 (en) * 2020-09-18 2024-10-16 Merck Sharp & Dohme Llc MODIFIED BENZOFURANCARBOXAMIDES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
DK1432707T3 (da) 2001-10-02 2012-06-11 Pharmacia & Upjohn Co Llc Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
EP1515967B1 (de) * 2002-06-10 2006-11-02 Bayer HealthCare AG 2-heteroarylcarbonsäureamide
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Also Published As

Publication number Publication date
EP1515967B1 (de) 2006-11-02
BR0312446A (pt) 2005-04-19
US9067931B2 (en) 2015-06-30
JP4542891B2 (ja) 2010-09-15
US10214524B2 (en) 2019-02-26
CA2488761C (en) 2011-05-31
WO2003104227A1 (de) 2003-12-18
US20110263591A1 (en) 2011-10-27
DE50305587D1 (en) 2006-12-14
CN1675204A (zh) 2005-09-28
AU2003238450A1 (en) 2003-12-22
EP1515967A1 (de) 2005-03-23
US20160122337A1 (en) 2016-05-05
ATE344262T1 (de) 2006-11-15
JP2005533052A (ja) 2005-11-04
CA2488761A1 (en) 2003-12-18
UY27841A1 (es) 2003-12-31
NO20050063L (no) 2005-01-06
MXPA04012439A (es) 2005-04-19
PL374551A1 (en) 2005-10-31
US7977485B2 (en) 2011-07-12
ES2276072T3 (es) 2007-06-16
US20140350008A1 (en) 2014-11-27
US20060160877A1 (en) 2006-07-20
US20120258964A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
NO20050063L (no) 2-heteroaryl karboksamider
NL300933I2 (nl) Letermovir
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
ATE453642T1 (de) Substituierte phenylaminopyrimidine
ATE408601T1 (de) Fredericamycin-derivate
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2005063734A3 (de) Substituierte thiophene
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
HK1083511A1 (en) Antibacterial amide macrocycles
NO20055741L (no) Nye kjemiske forbindelser
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
WO2003078430A8 (de) Essig- und propionsäureamide
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
HK1093729A1 (en) Substituted quinolones
TW200510449A (en) Acylated nonadepsipeptides
TW200621799A (en) Acylated nonadepsipeptides II
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
DE502005008925D1 (de) Substituierte nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
TW200510308A (en) Isophthalic acid derivatives
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
WO2004048321A8 (de) Phenylsulfoxid- und -sulfon-derivate
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens